Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study
British Journal of Haematology | March 3, 2014 | Volume: 165 | Issue: 4 | Pages: 510-518
10.1111/bjh.12780
| PMID 24579926